LY377604 + Sibutramine Hydrochloride Monohydrate: A Phase 2 Weight Loss Efficacy Study in Overweight/Obese Men and Women.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs LY 377604; Metoprolol; Sibutramine
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 02 Jun 2011 Planned end date changed from 1 Jul 2010 to 1 Jun 2010 as reported by ClinicalTrials.gov.
- 04 Jun 2010 Actual patient number (343) added as reported by ClinicalTrials.gov.